Releasing the restraints of vγ9vδ2 t-cells in cancer immunotherapy

HIGHLIGHTS

• who: Laura A. Ridgley and colleagues from the United Kingdom University of Kiel, Germany have published the research: Releasing the restraints of Vu03b39Vu03b42 T-cells in cancer immunotherapy, in the Journal: (JOURNAL)
• what: The aim of this study was to investigate further the expression of activatory and inhibitory immune receptors on Vd2 T-cells to determine the hierarchy of importance of these molecules in Vd2 T-cell function and the importance of stimulation conditions on activation of Vd2 T-cells. Vg9Vd2 T-cells express NK associated activatory receptors and inhibitory checkpoint receptors First, the authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.